BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25861831)

  • 1. 30 day mortality in adult palliative radiotherapy--A retrospective population based study of 14,972 treatment episodes.
    Spencer K; Morris E; Dugdale E; Newsham A; Sebag-Montefiore D; Turner R; Hall G; Crellin A
    Radiother Oncol; 2015 May; 115(2):264-71. PubMed ID: 25861831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality.
    Batumalai V; Descallar J; Delaney GP; Gabriel G; Wong K; Shafiq J; Vinod SK; Barton MB
    Radiother Oncol; 2021 Jan; 154():299-305. PubMed ID: 33217497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy and the introduction of a Rapid Access Palliative Clinic in a national radiation oncology network.
    O'Leary C; Cleary S; Linane H; Hamilton B; Jennings M; Lee Y; Lavan N; O'Reilly M; Twomey M
    Ir J Med Sci; 2024 Apr; 193(2):577-583. PubMed ID: 37606800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty-day mortality after palliative radiotherapy in advanced cancer patients: Optimizing end-of-life care in Asia.
    Kim MS; Cha H; You SH; Kim S
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):307-315. PubMed ID: 38450953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative radiotherapy: survival prognostic factors - single-centre retrospective cohort study.
    Cooper S; Denholm M; Malek AS; Rubasingham JA; Tsang D
    BMJ Support Palliat Care; 2024 Feb; ():. PubMed ID: 38378244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 30-day mortality following palliative radiotherapy.
    Kain M; Bennett H; Yi M; Robinson B; James M
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):570-579. PubMed ID: 32592442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative radiotherapy for advanced Cancer: Are we giving it to the right patient at the right time?
    Syadwa AS; Anita ZB
    Med J Malaysia; 2018 Aug; 73(4):190-196. PubMed ID: 30121680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of 30-day mortality as a quality metric for palliative radiation treatment: A population-based analysis from Queensland, Australia.
    Guan TL; Kutzko JH; Lunn DP; Dunn NA; Burmeister BH; Dadwal P; Tran N; Holt TR
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):316-324. PubMed ID: 38500454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation.
    Nieder C; Haukland EC; Mannsåker B; Dalhaug A
    Strahlenther Onkol; 2023 Mar; 199(3):278-283. PubMed ID: 36625853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients].
    Koswig S; Buchali A; Böhmer D; Schlenger L; Budach V
    Strahlenther Onkol; 1999 Oct; 175(10):509-14. PubMed ID: 10554646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia.
    Petrushevski AN; Gabriel GS; Hanna TP; Allen S; Allison RW; Barton MB
    Clin Oncol (R Coll Radiol); 2015 Apr; 27(4):205-12. PubMed ID: 25533480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidity on survival after palliative radiotherapy.
    Nieder C; Engljähringer K; Angelo K
    Strahlenther Onkol; 2014 Nov; 190(12):1149-53. PubMed ID: 25022254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.
    Haddad P; Wong RK; Pond GR; Soban F; Williams D; McLean M; Levin W; Bezjak A
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):430-4. PubMed ID: 16149286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in palliative radiotherapy for bone metastases within Western European countries.
    Lievens Y; Kesteloot K; Rijnders A; Kutcher G; Van den Bogaert W
    Radiother Oncol; 2000 Sep; 56(3):297-303. PubMed ID: 10974378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after palliative radiotherapy in geriatric cancer patients.
    Nieder C; Angelo K; Haukland E; Pawinski A
    Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
    Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
    Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?
    Gripp S; Mjartan S; Boelke E; Willers R
    Cancer; 2010 Jul; 116(13):3251-6. PubMed ID: 20564632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care and course of symptoms in palliative radiotherapy: a multicenter pilot study analysis.
    van Oorschot B; Schuler M; Simon A; Schleicher U; Geinitz H
    Strahlenther Onkol; 2011 Aug; 187(8):461-6. PubMed ID: 21786111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Did the pattern of practice in the prescription of palliative radiotherapy for the treatment of uncomplicated bone metastases change between 1999 and 2005 at the rapid response radiotherapy program?
    Bradley NM; Husted J; Sey MS; Sinclair E; Li KK; Husain AF; Danjoux C; Barnes EA; Tsao MN; Barbera L; Harris K; Chiu H; Doyle M; Chow E
    Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):327-36. PubMed ID: 18276125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis.
    Tang X; Hu Q; Chen Y; Wang X; Li X; Cheng K; Cao D
    BMJ Open; 2020 Jan; 10(1):e033120. PubMed ID: 31911518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.